The Effects of DPP-4 Inhibitors on Plasma Catecholamines and Their Metabolites in Patients with Type 2 Diabetes

被引：0
|
作者：
Park, Ie Byung
Lee, Daeho
Lee, Kiyoung
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-440-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
440-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The effects of DPP4 inhibitors on the levels of plasma catecholamines and their metabolites in patients with type 2 diabetes
    Kim, Tae Hun
    Lee, Kiyoung
    Park, Ie Byung
    Choi, Cheol Soo
    Ahn, Tae Hoon
    Lee, Dae Ho
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 156
  • [2] Effects of DPP-4 Inhibitors on Cardiovascular System in Type 2 Diabetes
    Ohno, Yasuhiro
    Tanaka, Yoichi
    Fujimoto, Mika
    Maruyama, Yasunori
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [3] DPP-4 inhibitors in the treatment of type 2 diabetes
    Duez, Helene
    Cariou, Bertrand
    Staels, Bart
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (07) : 823 - 832
  • [4] EFFECTS OF SGLT-2 INHIBITORS VERSUS DPP-4 INHIBITORS ON ANEMIA IN PATIENTS WITH TYPE 2 DIABETES
    Yang, Ai-Yu
    Chen, Hung-Chun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1007 - I1008
  • [5] The influence of DPP-4 inhibitors on fat metabolism in type 2 diabetes patients
    Ametov, A. S.
    Gusenbekova, D. G.
    DIABETOLOGIA, 2014, 57 : S378 - S378
  • [6] The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes
    Choe, Eun Yeong
    Cho, Yongin
    Choi, Younjeong
    Yun, Yujung
    Wang, Hye Jin
    Kwon, Obin
    Lee, Byung-Wan
    Ahn, Chul Woo
    Cha, Bong Soo
    Lee, Hyun Chul
    Kang, Eun Seok
    DIABETES & METABOLISM JOURNAL, 2014, 38 (03) : 211 - 219
  • [7] An update on DPP-4 inhibitors in the management of type 2 diabetes
    Cahn, Avivit
    Cernea, Simona
    Raz, Itamar
    EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (04) : 409 - 419
  • [8] A Clinical Overview of DPP-4 Inhibitors for Type 2 Diabetes
    Jeon, Michelle
    Took, Roxane L.
    Peters, Golden L.
    US PHARMACIST, 2018, 43 (10) : 49 - 56
  • [9] DPP-4 inhibitors and their potential role in the management of type 2 diabetes
    Barnett, A.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (11) : 1454 - 1470
  • [10] Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
    Gallwitz, Baptist
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2013, 6 : 1 - 9
12345